News Daily News Debating a PCI-First Strategy in Stable CAD: ORBITA-2 vs the Unconvinced Michael O'Riordan September 20, 2024
News Daily News ORBITA-STAR Highlights Variability in Symptom Changes Post-PCI Michael O'Riordan July 01, 2024
News Daily News Two ‘Evidence-Based Pathways’ for Stable Angina: ORBITA-2 Editorial Michael O'Riordan December 27, 2023
News Conference News AHA 2023 Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina Michael O'Riordan November 11, 2023
News Conference News EuroPCR 2023 Meta-analysis Finds No Excess Mortality Risk With Coronary Revascularization Michael O'Riordan May 19, 2023
News Daily News COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK Michael O'Riordan September 15, 2022
News Daily News Optimal Medical Therapy for Stable Angina: Which Drugs? How Long? Michael O'Riordan January 25, 2022
News Conference News EuroPCR 2021 Elective Revascularization, Better Long-term Survival: Meta-analysis Michael O'Riordan May 18, 2021
News Daily News Add-on CMS Payment Sweetens Shockwave Choice, but Cost Still Rankles Michael O'Riordan May 12, 2021
News Features ‘Salvage What We Can’: Cardiology Clinical Trials in Turmoil Amid COVID-19 Michael O'Riordan April 07, 2020
News Features Trial by Twitter: How a 280-Character Count Is Reshaping Cardiology Michael O'Riordan March 03, 2020
News Features Year in Review: ISCHEMIA Tops Coronary News in 2019 but Other Trials Shine, Too Michael O'Riordan December 09, 2019
News Conference News AHA 2019 More Ischemia on Stress Echo Equals Greater Angina Benefit With PCI: ORBITA Michael O'Riordan November 14, 2019
News Conference News TCT 2019 Intravascular Lithotripsy Shows Good Safety at 30 Days: DISRUPT CAD II Yael L. Maxwell October 08, 2019
News Analysis Hints at Survival Benefit With Revascularization in Stable Patients With Myocardial Ischemia Michael O'Riordan September 24, 2019
News Conference News CRT 2019 Blasting Off: Experience Grows for Intravascular Lithotripsy for Coronary Plaque Yael L. Maxwell March 15, 2019
News Conference News CRT 2019 ORBITA Absorbed: Principal Investigator Reflects on How Results Have Changed Her Practice Yael L. Maxwell March 07, 2019